AI Article Synopsis
- * These viruses create a diverse population of mutations (quasispecies) during replication, and ribavirin can increase this mutation rate, potentially killing the virus.
- * The article discusses using lethal mutagenesis as a strategy against these viruses, while highlighting the challenges that need to be overcome for it to be used in clinical settings.
Article Abstract
RNA viruses are responsible for numerous human diseases; some of these viruses are also potential agents of bioterrorism. In general, the replication of RNA viruses results in the incorporation of at least one mutation per round of replication, leading to a heterogeneous population, termed a quasispecies. The antiviral nucleoside ribavirin has been shown to cause an increase in the mutation frequency of RNA viruses. This increase in mutation frequency leads to a loss of viability due to error catastrophe. In this article, we review lethal mutagenesis as an antiviral strategy, emphasizing the challenges remaining for the development of lethal mutagenesis into a practical clinical approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/095632020401500101 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!